Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s428684 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Weinan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Choroidal Neovascularization, Macular Degeneration. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China.
ORCID-Profile: Weinan Hu, Wenting Cai, Tianyi Shen, Jing Yu
Zitieren
APA
Hu, W., Cai, W., Wu, Y., Ren, C., Yu, D., Li, T., Shen, T., Xu, D., & Yu, J. (2024). Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s428684
Vancouver
Hu W, Cai W, Wu Y, Ren C, Yu D, Li T, et al. Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s428684
BibTeX
@article{Hu2024,
author = {Hu, Weinan and Cai, Wenting and Wu, Yan and Ren, Chengda and Yu, Donghui and Li, Tingting and Shen, Tianyi and Xu, Ding and Yu, Jing},
title = {Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s428684}
}
EUVIMED